Thyroid C-cell Tumors: In rodent reports, semaglutide continues to be demonstrated to induce thyroid C-mobile tumors. It truly is unidentified no matter if this risk applies to humans, but semaglutide is contraindicated in sufferers with a personal or relatives historical past of medullary thyroid carcinoma (MTC) or patients with Numerous Endocrine